THE SIGNAL
BY
THE ARCH

Where Web3 founders, talent, and partners meet.

Directory

  • Partners Directory
  • All Categories
  • Compare Partners
  • For Founders
  • Find Your Match
  • Pricing

Get Involved

  • Get Listed
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Get Your Badge
  • 📅 Book a Call

News & Intelligence

  • Web3 News
  • Daily Digests
  • Intelligence Reports
  • Web3 Events
  • RSS Feed
  • Substack Newsletter

Company

  • About
  • How It Works
  • Manifesto
  • Demo

Legal

  • Privacy
  • Terms
  • Cookies

Resources

  • Guides
  • Sales Decks
  • Docs

© 2026 THE SIGNAL. All rights reserved.

THE SIGNAL
BY
THE ARCH

Where Web3 founders, talent, and partners meet.

Directory

  • Partners Directory
  • All Categories
  • Compare Partners
  • For Founders
  • Find Your Match
  • Pricing

Get Involved

  • Get Listed
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Get Your Badge
  • 📅 Book a Call

News & Intelligence

  • Web3 News
  • Daily Digests
  • Intelligence Reports
  • Web3 Events
  • RSS Feed
  • Substack Newsletter

Company

  • About
  • How It Works
  • Manifesto
  • Demo

Legal

  • Privacy
  • Terms
  • Cookies

Resources

  • Guides
  • Sales Decks
  • Docs

© 2026 THE SIGNAL. All rights reserved.

The Signal Logo
THE SIGNAL
PARTNERSINSIGHTSEVENTS
GET LISTED
News
YZi Labs Criticizes CEA Industries' Poison Pill Am...
The Block•Wednesday, January 7, 2026 at 09:35 AM•1 min read

YZi Labs Criticizes CEA Industries' Poison Pill Amid Boardroom Conflict

Share:
The Signal TakeBearish
RegulationAltcoinsTrading

YZi Labs, backed by Changpeng Zhao, has publicly criticized CEA Industries' adoption of a poison pill and recent bylaw changes. According to a post on X (formerly Twitter) on Wednesday, YZi Labs voiced its concerns regarding these measures. The development signals an escalation in the ongoing boardroom conflict between the two entities. A "poison pill" is a defense tactic used by a company to prevent a hostile takeover. The specific details of the bylaw changes and the extent of the conflict were not disclosed.

Read full story at The Block
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Inside the Growing ‘Digisexual’ Subculture of People in Relationships With AI

Decrypt •2h ago

Kalshi, Polymarket eye $20B valuations in potential fundraising: WSJ

Cointelegraph•3h ago

USDC Surpasses Tether as Stablecoin Volume Reaches Record $1.8 Trillion

Cointelegraph•4h ago

Why Bitcoin keeps snapping back to $70k — and the $13B options “magnet” behind it

CryptoSlate•5h ago
← Back to News Feed
The Signal Logo
THE SIGNAL
PARTNERSINSIGHTSEVENTS
GET LISTED
News
YZi Labs Criticizes CEA Industries' Poison Pill Am...
The Block•Wednesday, January 7, 2026 at 09:35 AM•1 min read

YZi Labs Criticizes CEA Industries' Poison Pill Amid Boardroom Conflict

Share:
The Signal TakeBearish
RegulationAltcoinsTrading

YZi Labs, backed by Changpeng Zhao, has publicly criticized CEA Industries' adoption of a poison pill and recent bylaw changes. According to a post on X (formerly Twitter) on Wednesday, YZi Labs voiced its concerns regarding these measures. The development signals an escalation in the ongoing boardroom conflict between the two entities. A "poison pill" is a defense tactic used by a company to prevent a hostile takeover. The specific details of the bylaw changes and the extent of the conflict were not disclosed.

Read full story at The Block
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Inside the Growing ‘Digisexual’ Subculture of People in Relationships With AI

Decrypt •2h ago

Kalshi, Polymarket eye $20B valuations in potential fundraising: WSJ

Cointelegraph•3h ago

USDC Surpasses Tether as Stablecoin Volume Reaches Record $1.8 Trillion

Cointelegraph•4h ago

Why Bitcoin keeps snapping back to $70k — and the $13B options “magnet” behind it

CryptoSlate•5h ago
← Back to News Feed